SCHEMBL3662977

SCHEMBL3662977

BrNc1cc2ccccc2cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 2/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2A6 P11509 1/20 0.48
PDPK1 O15530 1/20 0.48
MTOR P42345 1/20 0.44
NOTUM Q6P988 1/20 0.41
NPC1 O15118 3/20 0.40
PLAU P00749 1/20 0.40
EGFR P00533 1/20 0.40
WNT3A P56704 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAP4K4 O95819 1/20 0.38
TYK2 P29597 1/20 0.38
MINK1 Q8N4C8 1/20 0.38
SRPK1 Q96SB4 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
RAB9A P51151 2/20 0.38
IGF1R P08069 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13804176 0.78 CYP1A2 (0.54) CHEK1CYP1A2CYP2A6PDPK1MTOR
SCHEMBL25242404 0.78 PDPK1 (0.54) CHEK1CYP1A2CYP2A6PDPK1MTOR
Hydrochloric Acid SCHEMBL7398907 0.77 CYP1A2 (0.52) CHEK1CYP1A2CYP2A6PDPK1MTOR
SCHEMBL1486301 0.75 CHEK1 (0.50) CHEK1CYP1A2CYP2A6PDPK1MTOR
SCHEMBL1922139 0.75 PDGFRB (0.56) CHEK1CYP1A2CYP2A6PDPK1NPC1
SCHEMBL12915410 0.75 CYP1A2 (0.50) CHEK1CYP1A2CYP2A6PDPK1MTOR
SCHEMBL211712 0.74 CHEK1 (0.49) CHEK1CYP1A2CYP2A6PDPK1MTOR
SCHEMBL6684693 0.74 CHEK1 (0.49) CHEK1CYP1A2CYP2A6PDPK1MTOR
SCHEMBL14599973 0.74 CYP1A2 (0.48) CHEK1CYP1A2CYP2A6PDPK1MTOR
SCHEMBL28512102 0.74 USP30 (0.49) CHEK1CYP1A2CYP2A6PDPK1MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231641-A2 QUINOXALINE AND QUINOLINE DERIVATIVES AS KINASE INHIBITORS UCB Pharma, S.A. (BE) 2010-09-29 EP disclosed
WO-2009081105-A2 QUINOXALINE AND QUINOLINE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-07-02 WO disclosed
EP-1427421-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS Amgen Inc. (US) 2004-06-16 EP disclosed
WO-2003018021-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS AMGEN INC. (US) 2003-03-06 WO disclosed